Jan
16

Hedge Fund Can Give Olympus a Clearer Focus

By

Given its history of controversy, the camera and medical-device maker’s embrace of ValueAct is encouraging.

Can you teach an old dog new tricks? Olympus Corp. investors appear willing to bet so.

Shares of the camera and medical-device maker, which was mired in a $1.7 billion accounting scandal in 2011, have surged to their highest in almost three years after the Japanese company announced a leadership and board shakeup in response to pressure from U.S. hedge fund ValueAct Capital Management LP.

Hedge Fund Can Give Olympus a Clearer Focus

Share
Categories : Hedge Funds

Leave a Reply

You must be logged in to post a comment.